Related Experiment Videos
[Analysis of antihypertensive therapy in patients before acute cerebral ischemic disease]
Insights
Many hypertensive patients with ischemic brain disease require therapy adjustments due to inadequate drug choices and dosages. Poor adherence and infrequent monitoring further compromise hypertension management in this population.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Context:
- Hypertensive disease poses significant risks for patients with ischemic brain disease.
- Current therapeutic strategies for hypertension in this cohort require evaluation.
- Antihypertensive drug administration and patient adherence are critical factors.
Purpose:
- To analyze the adequacy of therapeutic programs for hypertensive patients with ischemic brain disease.
- To assess the effectiveness of different antihypertensive drug classes.
- To identify challenges in hypertension management within this patient group.
Summary:
- Over 50% of patients needed therapy changes, introducing drugs from different classes.
- Inadequate drug dosages and minimal effective doses were frequently observed.
- More than 80% of patients exhibited irregular therapy intake, with only 18% having regular medical controls.
Impact:
- Highlights the need for optimized therapeutic programs for hypertension control in ischemic brain disease patients.
- Underscores the critical issue of poor patient adherence to prescribed antihypertensive therapies.
- Emphasizes the importance of regular disease monitoring and consistent treatment adherence for improved patient outcomes.
Abstract:
The adequacy of therapeutic program for hypertensive disease in the patients with ischemic brain disease was analyzed in the study related to the administration of the drugs divided by the groups of antihypertensive drugs. The results had demonstrated that in over 50% patients the therapy had to be changed by introducing at least one hypertensive drug from the other group. In many cases were observed inadequate doses of antihypertensive drugs and the prescription of antihypertensive drug in minimal dose, although therapeutic response was not adequate. In significant number of cases (over 80%), the patients were irregularly taking the prescribed therapy, and only 18% had the regular controls. The results of this investigation indicated that on one side did not exist the adequate therapeutic program for hypertension control and on the other the significant number of patients irregularly used the proposed therapy and did not control the disease regularly.